TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Homo sapiens (Human))
Nosopharm
US Patent
Nosopharm
US Patent
Affinity DataIC50: <30nMAssay Description:Interaction with N-type calcium channels was assessed with radiolabelled a competitive binding assay, applying the procedure described by Wagner et a...More data for this Ligand-Target Pair